ZA92110B - Pharmaceutical compositions. - Google Patents

Pharmaceutical compositions.

Info

Publication number
ZA92110B
ZA92110B ZA92110A ZA92110A ZA92110B ZA 92110 B ZA92110 B ZA 92110B ZA 92110 A ZA92110 A ZA 92110A ZA 92110 A ZA92110 A ZA 92110A ZA 92110 B ZA92110 B ZA 92110B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA92110A
Other languages
English (en)
Inventor
Robert Charles Hider
Timothy Edward Alexander Peto
Susan Whitehead
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA92110B publication Critical patent/ZA92110B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA92110A 1991-01-09 1992-01-08 Pharmaceutical compositions. ZA92110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919100465A GB9100465D0 (en) 1991-01-09 1991-01-09 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA92110B true ZA92110B (en) 1993-07-08

Family

ID=10688205

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92110A ZA92110B (en) 1991-01-09 1992-01-08 Pharmaceutical compositions.

Country Status (6)

Country Link
EP (1) EP0494754A1 (fr)
JP (1) JPH06507377A (fr)
CA (1) CA2100158A1 (fr)
GB (2) GB9100465D0 (fr)
WO (1) WO1992012131A1 (fr)
ZA (1) ZA92110B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9209078D0 (en) * 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
FR2725718B1 (fr) * 1994-10-14 1997-01-24 Virbac Lab Bis-2-aminopyridines, leur procede de preparation et leurs applications
JPH0925234A (ja) * 1995-07-12 1997-01-28 Wakunaga Pharmaceut Co Ltd 脳疾患改善剤
EP0768302B1 (fr) * 1995-09-29 2005-07-06 Novartis AG Hydroxypyridinones
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
WO2007138048A1 (fr) * 2006-05-31 2007-12-06 Glaxo Group Limited Nouveaux composés hétérocycliques
UY30986A1 (es) 2007-03-28 2008-09-02 Apotex Technologies Inc Derivados fluorinados de deferiprona
WO2009129592A1 (fr) 2008-04-25 2009-10-29 Apotex Technologies Inc. Formulation liquide de défériprone de goût agréable
CN102239155A (zh) * 2008-12-11 2011-11-09 盐野义制药株式会社 生产麦芽糖醇醚的方法和中间体
MX2012000247A (es) 2009-07-03 2012-03-26 Apotex Technologies Inc Derivados fluorados de 3-hidroxipiridin-4-onas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
EP0305646B1 (fr) * 1983-03-24 1996-11-13 Btg International Limited 3-Hydroxypyrid-ones et compositions pharmaceutiques
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload

Also Published As

Publication number Publication date
GB9200253D0 (en) 1992-02-26
CA2100158A1 (fr) 1992-07-10
GB2251617B (en) 1995-02-01
JPH06507377A (ja) 1994-08-25
EP0494754A1 (fr) 1992-07-15
GB9100465D0 (en) 1991-02-20
GB2251617A (en) 1992-07-15
WO1992012131A1 (fr) 1992-07-23

Similar Documents

Publication Publication Date Title
PH31205A (en) Pharmaceutical composition.
GR3036937T3 (en) Pharmaceutical formulations.
GR3032366T3 (en) Pharmaceutical cyclosporin composition.
ZA926020B (en) Pharmaceutical combination formulation.
ZA922834B (en) Pharmaceutical compositions
OA09810A (en) Pharmaceutical composition.
GB9108080D0 (en) Pharmaceutical composition
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
ZA92110B (en) Pharmaceutical compositions.
ZA918381B (en) Pharmaceutical compositions.
GB9214757D0 (en) Pharmaceutical compositions
ZA927369B (en) Pharmaceutical compositions.
GB9221212D0 (en) Pharmaceutical compositions
ZA92192B (en) Pharmaceutical compositions.
GB2252497B (en) Pharmaceutical composition
ZA929372B (en) Pharmaceutical composition.
ZA93286B (en) Pharmaceutical compositions.
GB9111477D0 (en) Pharmaceutical composition
HU9403398D0 (en) Pharmaceutical compositions based on plasmaproteins
GB9123423D0 (en) Pharmaceutical compositions
GB9126766D0 (en) Pharmaceutical compositions
GB9118128D0 (en) Pharmaceutical compositions
GB9119048D0 (en) Pharmaceutical compositions
GB9113805D0 (en) Pharmaceutical compositions
GB9110884D0 (en) Pharmaceutical compositions